Introduction
The Stevens-Johnson syndrome (SJS) is a life-threatening skin condition caused by a hypersensitivity complex, which affects the skin and the mucous membranes. This syndrome is closely related to the application of antiepileptic drugs (AEDs). 1 Most cases are caused by aromatic AEDs, such as phenytoin, carbamazepine, oxcarbazepine, phenobarbital, lamotrigine, and other aromatic drugs.
2 Levetiracetam (LEV), the S-enantiomer of a-ethyl-2-oxo-1-pyrrolidine acetamide, is an AED with a novel mechanism of action. 3 Arif et al. reviewed 1890 cases and determined the predictors and relative incidences of AED-related rash in patients who take 15 different AEDs. In that study, 0.6% of the patients who started LEV treatment developed rashes. 4 To the best of our knowledge, the current paper presents the first case report on LEV therapy-induced SJS in a child. LEV-induced cutaneous drug eruptions are rare. However, the case discussed in this work may be useful for AED selection and counseling of individual patients.
Case
A female patient, 2.25 years old, underwent hypothermic open heart surgery for congenital heart disease with a pulmonary artery sling, ventricular septal defect, patent ductus arteriosus, and cleft mitral valve. The operation was successful, and her body temperature was normal. Cardiorespiratory arrest occurred on the seventh day after her operation. She was treated with tracheal cannulation and ventilator-assisted respiration. Seizures occurred on the eighth day after her operation so she was given phenobarbital at 5 mg/kg/day. Considering her declining status and poorly controlled seizures, 10 mg/kg/day oxcarbazepine (OXC) was added on the 32nd day post-operation. Rashes began to appear on her torso, and her body temperature reached 37(8 8C on the 34th day (i.e., two days after OXC was administered). On the 35th day, she developed on her torso an erythematous maculopapular rash without exudates, which grew pale upon pressure. Considering OXC allergy, the drug was changed to LEV (20 mg/kg/day). Upon subsequent observation, rashes no longer developed, and the primary rash began to disappear. The ventilator was no longer required on the 39th day after operation. However, LEV dosage was increased to 30 mg/kg/day on the 41st day, because the seizures began to recur frequently. Once again, her body temperature increased, reaching up to 38.8 8C. Moreover, the rashes developed again on the ninth day after LEV was administered. On the 50th day post-operation, her body temperature reached 40 8C. The fever was persistent, and more rashes appeared on her face and torso, which spread to all four limbs. The rashes on her face were confluent with patchy congested areas; these rashes were similar to herpes erosions. Exudation occurred on her mouth and lips. As her illness progressed, the erosions and exudation appeared on the mucous membranes of her vulva and anus (Fig. 1) . She was then diagnosed with SJS, which may have been caused by LEV. LEV was stopped immediately, and methylprednisolone (20 mg/kg/day) was added to her drug regimen. In addition, skin and membrane care was enhanced to avoid secondary infections and maintain the function of the internal organs without contacting other allergens. Her fluid and caloric intake was carefully controlled. Topiramate was used as the primary AED. Her body temperature returned to normal two days after LEV was withdrawn (on the 52nd day post-operation).
No new rashes appeared on the 58th day. The rest of her stay became normal. She continued to take phenobarbital and topiramate and was discharged from the hospital on the 88th day after her operation ( Fig. 2) .
Discussion
Antiepileptic drug hypersensitivity syndrome (AHS) is a relatively rare side effect of Antiepileptic drugs (AEDs), and ranges from maculopapular eruption to severe Stevens-Johnson syndrome or toxic epidermal necrolysis. 2 AHS is closely related to the application of AEDs, and most of them are caused by the aromatic AEDs, such as phenytoin, carbamazepine, and other aromatic drugs. It can also be caused by drugs such as dapsone. The syndrome is defined by the triad of fever, skin rash, and internal organ involvement. The incidence occurs in approximately 1 in 3,000 exposures. 2 Hypersensitivity syndrome reactions to AEDs are associated with severe clinical cutaneous adverse reactions (SCAR). 5 SCAR to drugs include acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome or also called drug-induced hypersensitivity syndrome), SJS, and toxic epidermal necrolysis. 6 SJS is an uncommon but potentially life-threatening idiosyncratic drug reaction usually caused by aromatic anticonvulsants. The importance of early diagnosis and ability to distinguish SJS from other diseases cannot be overemphasized, because the risk is largely confined to the first two months of treatment. 1 Patients who receive LEV treatment rarely develop rashes. 2 In cases of AED allergy, doctors choose LEV as an alternative drug. SJS is not a reported side effect of LEV. Alkhotani 7 reported a case of LEVinduced angioedema in a patient with a previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine. The reported case is very similar to the case presented in the current paper. 7 Thus, a question arises: can a patient with a known sulfa allergy receive LEV treatment? The previous case 7 and the case we present in this paper reveal that LEV allergy occurs in patients with previous anticonvulsant hypersensitivity reactions. However, attention should also be given to the cross-reactivity between drugs. The cross-reactivity between phenytoin, carbamazepine, and phenobarbital is as high as 70.40%. 8 The most common cases involve aromatic drugs that exhibit significant cross-reactivity due to large differences among their chemical structures. 9 By contrast, other AEDs such as LEV, topiramate, gabapentin, and tiagabine are rarely associated with rashes. Wang et al. 10 reviewed the medical records of all AED treatments in 3,793 consecutive Chinese patients with epilepsy in our hospital. Hirsch et al. 11 reviewed the incidence of AED-related rash in 1,875 outpatients. However, some studies have reported cases of dose-related LEV-induced reticulated drug eruption, 12 LEV-induced drug reaction with eosinophilia and systemic symptom syndrome, 13 and severe acute hepatitis in DRESS syndrome. 14 Although LEV is rarely associated with cutaneous adverse reactions, clinicians should be aware of its potential to cause hypersensitivity syndrome reactions.
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[ ( F i g . _ 1 ) T D $ F I G ] Fig. 1 . Rashes appeared on her face and torso that spread to all four limbs. The rashes on her face were confluent with patchy congested areas and were similar to herpes erosions and exudation occurred on her mouth and lips on the nine days after increasing the Levetiracetam dosage (30/kg/day).
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